Amvis : Q3Q3 FAQ （729KB）

Third Quarter of the Fiscal Year Ending September 30, 2023

FAQ

Amvis Holdings, Inc.

August 9, 2023

©Amvis Holdings, Inc.

Summary

1. Number of Facilities / Bed Capacity

1. Utilization Rates
   Q Net Sales
   Q Operating Profit / EBITDA
   Q Cash Flow
   Q Equity Ratio
   Q Facility Opening Strategy

1. Recruiting

1. Promoting Occupancy

1. Headquarters-FocusedSystem
   Q Wage Increase

1. Competition

1. Macro Environment

1. COVID-19

1. Shareholder Return

1. Sustainability

1. Regional Healthcare Revitalization Project

1. IR Activities

©Amvis Holdings, Inc.	2

Key Financial Indicators:

Number of Facilities / Bed Capacity

Q

A

How do you plan to expand the number of facilities / bed capacity?

We continue to accelerate the openings of Ishinkan to reach the Amvis 2025 target of 127 facilities (6,328 beds).

We have already announced plans to open 25 new facilities and expand 1 facility (1,308 beds) for FY24, exceeding the target of 23 new facilities (1,161 beds) set in Amvis 2025, and we plan to further accelerate facility openings toward the end of FY25.

The basic capacity per facility is about 50 beds. We also aim to open about 1-2 large facilities with 70 beds per year.

©Amvis Holdings, Inc.	3

Key Financial Indicators: Utilization Rates

Q

A

What are your current utilization rates and forecast for FY23?

In FY23 Q3 YTD, we maintained stable operation at existing facilities, and the start of 13 new facilities was also favorable as we expected. Utilization rates as a whole surpassed our target for stable operations.

As forecast for FY23 full-year, we continue to expect the utilization rate to be 82-85%, which is our target for stable operations.

Since Ishinkan mainly accepts patients in the terminal stages of cancer, about 10 patients per month are leaving or passing away at each facility, which makes it difficult to maintain the utilization rates in the 90% range.

©Amvis Holdings, Inc.	4

Key Financial Indicators: Net Sales

Q

A

What is your analysis of net sales for FY23 Q3?

As mentioned on the previous page, utilization rates were favorable. As a result, net sales were also in line with our expectations. In FY23, we expect net sales to be immaterially different from our initial forecast.

Until FY22, we limited the number of facility openings in Q4, but in FY23 Q4, we plan to open 2 new facilities in August and 4 new facilities in September and expand 1 facility.

Based on inflation of wood, energy resources, and goods used at the facilities, we raised patient payments by about 7,000 yen per month in FY23, and plan to raise them again by about 4,000 yen per month in October 2023.

©Amvis Holdings, Inc.	5